1. Belay ED, Bresee JS, Holman RC et al. Reye’s syndrome in the United States from 1981 through 1997. NEJM. 1999;340(18):1377–82.

2. U.S. Food and Drug Administration. Advanced notice of proposed rulemaking: Labeling for salicylate-containing products. Fed. Reg. 1982;47: 57886.

3. Lurie P, Wolfe S. Aspirin and Reye’s syndrome. In Paradigms for Change: A public health textbook for medical, dental, pharmacy, and nursing students. Washington, DC: Public Citizen Health Research Group, unpublished.

4. Hilts P. Protecting America’s Health: The FDA, Business, and One Hundred Years of Regulation. New York: Knopf, 2003.

5. Brown and Williamson. Smoking and health proposal. Brown and Williamson document no. 680561778–1786, 1969. Available at: http://legacy.library.ucsf.edu/tid/nvs40f00. Accessed in June 2007.

6. Whitman CT. Effective policy making: The role of good science. Remarks at the National Academy of Science’s Symposium on Nutrient Over-enrichment of Coastal Waters. October 13, 2000. Available at: http://www.usembassy.it/file2001_01/alia/a0010407.htm. Accessed in June 2007.

7. Michaels D, Bingham E, Boden L. et al. Advice without dissent. Science. 2002;298(5594):703.

8. Luntz F. Memo: The environment: A cleaner, safer, healthier America; ca. 2003. Available at: http://www.ewg.org:16080/briefings/luntzmemo. Accessed in October 2006.

9. Herrick C, Jamieson D. Junk science and environmental policy: Obscuring public debate with misleading discourse. Philos Public Policy Q. 2001;21:11–16.